Name
Peter Jones
CoPED ID
d04ba734-1302-4621-9144-28d4fd6e18de
None
OrcidID
None
LinkedIn URL
Projects in CoPED
A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2)
Status: Active
Total funding: £4,939,666
From: July 31, 2016
To: March 31, 2024
Organisations: 3
People: 5
Organisations
Links
Added to CoPED
April 11, 2022, 1:37 a.m.
Last update
Nov. 27, 2023, 1:16 p.m.